Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

China · Delayed Price · Currency is CNY

20.50

+0.39 (1.94%)

Jun 18, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medicine Manufacturing	220.23M	324.82M	364.18M	548.99M	584.29M
Medicine Manufacturing Growth	-32.20%	-10.81%	-33.66%	-6.04%	37.41%
Total	220.23M	324.82M	364.18M	548.99M	584.29M
Total Growth	-32.20%	-10.81%	-33.66%	-6.04%	37.41%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	220.23M	324.82M	364.18M	548.99M	584.29M
China Growth	-32.20%	-10.81%	-33.66%	-6.04%	37.41%
Total	220.23M	324.82M	364.18M	548.99M	584.29M
Total Growth	-32.20%	-10.81%	-33.66%	-6.04%	37.41%